LEDIFOS SOFOSBUVIR AND LEDIPASVIR TABLETS

Get a Price/Quote

LEDIFOS SOFOSBUVIR AND LEDIPASVIR TABLETS Specification

Origin of Medicine
India

Indication
Treatment of Hepatitis C Virus (HCV) Genotype 1

Pacakaging (Quantity Per Box)
28 tablets

Dosage Form
Film-coated tablet

Salt Composition
Sofosbuvir 400 mg & Ledipasvir 90 mg

Drug Type
Allopathic

Ingredients
Sofosbuvir and Ledipasvir

Physical Form
Tablets

Function
Antiviral therapy for Hepatitis C

Recommended For
Chronic Hepatitis C infection

Dosage
As directed by the physician

Dosage Guidelines
One tablet daily or as prescribed

Suitable For
Adults

Quantity
28 tablets per box

Storage Instructions
Store in a cool, dry place below 30C, protect from light

Administration Route
Oral

Brand Name
LEDIFOS

Trade Name
LEDIFOS

Marketed By
Hetero Healthcare Ltd.

Color
Yellowish

Therapeutic Class
Direct Acting Antiviral (DAA)

Prescription Required
Yes

Shelf Life
24 months from the date of manufacture

Caution
Not recommended for use in children under 18 years, pregnant or breastfeeding women without medical advice

Side Effects
May include fatigue, headache, nausea

LEDIFOS SOFOSBUVIR AND LEDIPASVIR TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

About LEDIFOS SOFOSBUVIR AND LEDIPASVIR TABLETS

Specification :-

Brand Name : Ledifos
Content : Sofosbuvir Ledipasvir
Strength : Sofosbuvir 400mg And Ledipasvir 90mg
Packing : Pack of 28 Tablets
Uses : Treating chronic hepatitis C virus (HCV) infection in certain patients..

Note :-Ledifos Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..........

Comprehensive Antiviral Treatment

LEDIFOS combines Sofosbuvir and Ledipasvir to target and inhibit the Hepatitis C virus (HCV), providing a direct-acting antiviral approach. This treatment is particularly recommended for adults diagnosed with chronic HCV genotype 1 infection and is known for its convenience, taken orally once daily.

Safe Storage and Handling

Keep LEDIFOS tablets in a cool, dry place below 30C and protect them from light. Proper storage ensures the medication maintains its efficacy throughout its 24-month shelf life. Always store out of reach of children and dispose of unused tablets safely, following your healthcare providers guidance.

FAQs of LEDIFOS SOFOSBUVIR AND LEDIPASVIR TABLETS:

Q: How should I take LEDIFOS tablets for Hepatitis C treatment?

A: LEDIFOS is taken orally, usually one film-coated tablet daily or as directed by your physician. Swallow the tablet whole with water, and try to take it at the same time each day for best results.

Q: What conditions is LEDIFOS prescribed for?

A: LEDIFOS is specifically indicated for the treatment of chronic Hepatitis C Virus (HCV) genotype 1 infection in adults. It is not suitable for children under 18 years of age.

Q: When should I avoid using LEDIFOS?

A: LEDIFOS should not be used without medical advice if you are pregnant, breastfeeding, or under 18 years old. Discuss your medical history and other medications with your healthcare provider prior to starting the treatment.

Q: Where should I store LEDIFOS tablets?

A: Store LEDIFOS in a container placed in a cool, dry area below 30C and protect it from direct light. This ensures the tablets remain effective up to their expiry date.

Q: What are the common side effects associated with LEDIFOS?

A: Some patients experience mild side effects such as fatigue, headache, or nausea. If these become severe or persistent, contact your healthcare provider for advice.

Q: What benefits can I expect from LEDIFOS treatment?

A: LEDIFOS targets and inhibits the replication of the Hepatitis C virus, offering a significant chance of clearing the infection and helping to restore liver health in eligible adult patients.

Tell us about your requirement